Regarding sulfonylureas, a retrospective study conducted using the United Health Group Clinical Discovery Database revealed that both sulfonylureas and insulin were associated with increased odds of hospitalization among individuals with T2DM [61]. Here, INS is linked to type 2 diabetes mellitus.